# Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee

> **NCT02187549** · NA · UNKNOWN · sponsor: **Fidia Farmaceutici s.p.a.** · enrollment: 332 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DEVICE:** HYMOVIS
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT02187549
- **Lead sponsor:** Fidia Farmaceutici s.p.a.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2016-02
- **Final completion:** 2016-03
- **Target enrollment:** 332 (ESTIMATED)
- **Last updated:** 2015-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02187549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02187549, "Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02187549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*